Harald Hampel to Become Anavexs Scientific Advisory Board Member
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS)…
Pharmaceuticals, Biotechnology and Life Sciences
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS)…
Quantum Pharma a service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors has anounced first large-scale NHS homecare contract…
Simulations Plus, Inc, a provider of consulting services and software for pharmaceutical discovery and development, announced on September 17 that…
DEA Acting Administrator Chuck Rosenberg has announced that the 10th National Prescription Drug Take-Back will take place September 26 from…
The Supervisory Board of Bayer has approved the reorganization proposed by the Board of Management, so that from January 1,…
Novartis announced on September 18 that Swissmedic has approved Entresto (sacubitril/valsartan), previously known as LCZ696, to reduce the risk of cardiovascular…
FDA announced on September 15 that Butala Emporium, Inc of Jackson Heights, NY, is voluntarily recalling eleven Ayurvedic (dietary) supplements because the products…
Allergan plc and Gedeon Richter Plc. have announced that the U.S. Food and Drug Administration (FDA) has approved Vraylartm (cariprazine) capsules,…
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly reported that the Company’s Jardiance (empagliflozin) had reduced the risk of the…
Allergan and U.S. Women’s Health Alliance (USWHA), an organization focused on promoting high-quality, affordable healthcare for women, have announced an…
You must be logged in to post a comment.